3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
7
Leiomyoma
5
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
2
Breast Neoplasms, Male
2
Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
1
Neoplasms
1
Gulf War Illness
1
Fallopian Tube Neoplasms
1
Endometrial Stromal Tumors
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Female
1
Interventions
bicalutamide
4
pembrolizumab
1
nilutamide
1
exemestane
1
darolutamide
1
cabazitaxel
1
apalutamide
1
abemaciclib
1
Vorinostat
1
Tamoxifen
1
Prophylactic Mastectomy
1
Panobinostat
1
Mifepristone
1
Letrozole
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Goserelin
1
Dasatinib
1
Aromatase Inhibitors
1
Antiemetics
1
Anastrozole
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bulbo-Spinal Atrophy, X-Linked
×
Mifepristone
×
Clear all
NCT05062174
2022-12-15
Breast Cancer BRCA1 Carriers: a Pilot Study
Indiana University
Withdrawn